Immunocore Holdings PLC Sponsored ADR IMCR

30.72 (0.57) (1.82%) as of 25 Sep
Market cap
$1.6B
P/E
0.0×
Growth Flags show if company had growth for consecutive years

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Revenue
400.02 310.20 249.43 174.36 36.47 38.67 32.78 31.54
Revenue Growth
28.95% 24.37% 43.05% 378.12% (5.69%) 17.97% 3.92% (3.68%)
Cost of Revenue
5.09 2.73 1.04 1.09 — — — —
Gross Profit
394.93 307.47 248.39 173.27 36.47 38.67 32.78 —
R&D Expenses
274.87 222.15 163.55 101.92 100.69 96.05 127.68 111.76
SG&A Expenses
165.41 155.78 144.50 123.06 121.56 58.73 56.42 37.98
Operating Income
(45.35) (70.46) (59.65) (51.71) (185.86) (110.67) (151.08) —
Interest Expense (Operating)
— — — — — — — 1.12
Non-operating Income/Expense
26.25 17.52 (1.24) 10.83 (7.93) (1.50) (10.05) 8.88
Non-operating Interest Expenses
12.17 18.84 5.15 5.41 7.99 4.33 11.98 1.10
EBT
(19.10) (52.94) (60.89) (40.88) (193.79) (112.17) (161.13) (117.89)
Income Tax Provision
16.41 (1.85) (5.60) 11.66 (12.93) (17.03) (28.42) (22.38)
Income after Tax
(35.51) (51.09) (55.29) (52.54) (180.86) (95.14) (132.71) —
Net Income Common
(35.51) (51.09) (55.29) (52.54) (180.86) (95.14) (132.71) (95.51)
EPS (Basic)
(0.71) (1.02) (1.13) (1.09) (4.19) (3.58) (29.76) (2.26)
EPS (Diluted)
(0.71) (1.02) (1.13) (1.09) (4.19) (3.58) (29.76) (2.26)
Shares (Basic, Weighted)
50.35 49.99 48.89 45.72 42.49 26.52 4.46 —
Shares (Diluted, Weighted)
50.35 49.99 48.89 45.72 42.49 26.52 4.46 42.30
Gross Margin
98.73% 99.12% 99.58% 99.38% 100.00% 100.00% 100.00% 0.00%
EBIT Margin
(11.34%) (22.71%) (23.91%) (29.66%) (509.66%) (286.22%) (460.95%) (806.21%)
EBT margin
(4.77%) (17.07%) (24.41%) (23.45%) (531.40%) (290.10%) (491.60%) (373.79%)
Net Profit Margin
(8.88%) (16.47%) (22.17%) (30.13%) (495.94%) (246.04%) (404.89%) (302.82%)
Free Cash Flow Margin
(3.76%) 6.75% (1.00%) (29.77%) (365.92%) (209.12%) (411.27%) (70.29%)
EBITDA
(42.09) (66.26) (55.56) (46.37) (176.22) (99.15) (139.32) (118.20)
EBIT
(45.35) (70.46) (59.65) (51.71) (185.86) (110.67) (151.08) (254.28)
Income from Continuous Operations
(35.51) (51.09) (55.29) (52.54) (180.86) (95.14) (132.71) —
Consolidated Net Income/Loss
(35.51) (51.09) (55.29) (52.54) (180.86) (95.14) (132.71) (95.51)
EPS (Basic, from Continuous Ops)
(0.71) (1.02) (1.13) (1.15) (4.26) (3.59) (29.76) —
EPS (Basic, Consolidated)
(0.71) (1.02) (1.13) (1.15) (4.26) (3.59) (29.76) —
EPS (Diluted, from Cont. Ops)
(0.71) (1.02) (1.13) (1.15) (4.26) (3.59) (29.76) —
Shares (Diluted, Average)
50.35 49.99 48.89 45.68 42.38 26.52 — —
EPS (Diluted, Consolidated)
(0.71) (1.02) (1.13) (1.15) (4.26) (3.59) (29.76) —
EBITDA Margin
(10.52%) (21.36%) (22.27%) (26.60%) (483.22%) (256.42%) (425.05%) (374.75%)
Operating Cash Flow Margin
(2.68%) 8.40% 1.18% (28.22%) (362.41%) (201.15%) (394.94%) (70.29%)

Fold the line items

In millions of $ except per-share values · columns are period end dates